Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

breast

  • Open Access
    Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study
    Joanne E. Mortimer, James R. Bading, Paul H. Frankel, Mary I. Carroll, Yuan Yuan, Jinha M. Park, Lusine Tumyan, Nikita Gidwaney, Erasmus K. Poku, John E. Shively and David M. Colcher
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1145-1148; DOI: https://doi.org/10.2967/jnumed.121.262940
  • You have access
    Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT
    Gary A. Ulaner, David M. Hyman, Dara S. Ross, Adriana Corben, Sarat Chandarlapaty, Shari Goldfarb, Heather McArthur, Joseph P. Erinjeri, Stephen B. Solomon, Hartmuth Kolb, Serge K. Lyashchenko, Jason S. Lewis and Jorge A. Carrasquillo
    Journal of Nuclear Medicine October 1, 2016, 57 (10) 1523-1528; DOI: https://doi.org/10.2967/jnumed.115.172031
  • You have access
    Breast-Dedicated Radionuclide Imaging Systems
    David F.C. Hsu, David L. Freese and Craig S. Levin
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 40S-45S; DOI: https://doi.org/10.2967/jnumed.115.157883
  • You have access
    Molecular Imaging of Biomarkers in Breast Cancer
    Gary A. Ulaner, Chris C. Riedl, Maura N. Dickler, Komal Jhaveri, Neeta Pandit-Taskar and Wolfgang Weber
    Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 53S-59S; DOI: https://doi.org/10.2967/jnumed.115.157909
  • You have access
    18F-Fluoride PET Used for Treatment Monitoring of Systemic Cancer Therapy: Results from the National Oncologic PET Registry
    Bruce E. Hillner, Barry A. Siegel, Lucy Hanna, Fenghai Duan, Bruce Quinn and Anthony F. Shields
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 222-228; DOI: https://doi.org/10.2967/jnumed.114.150391
  • You have access
    A Molecular Approach to Breast Imaging
    Amy M. Fowler
    Journal of Nuclear Medicine February 1, 2014, 55 (2) 177-180; DOI: https://doi.org/10.2967/jnumed.113.126102
SNMMI

© 2025 SNMMI

Powered by HighWire